American Journal

World's Most Influential People in Ophthalmology

Retrieved on: 
木曜日, 5月 9, 2024
Education, FDA, Bascom Palmer Eye Institute, Genetics, Teaching, Surgeon, Paratriathlon, Neuro-ophthalmology, Leach, Strabismus, Cataract, Knowledge, Bascom H. Palmer, Gedde, Eye, DRS, Retina, Vision science, Quality of life, Publication, Research, Bevacizumab, Artificial intelligence, Suture, Health, M.A, Choroideremia, Medeiros, Vance DeGeneres, University, Retinitis pigmentosa, Epidemiology, American Journal, Power, Patient, Physician, Uveitis, Glaucoma, Nursing

MIAMI, May 9, 2024 /PRNewswire/ -- Fifteen Bascom Palmer Eye Institute physicians were selected for the 2024 Power List, a prestigious selection of the world's 100 most influential people shaping the future of eye care, as published by The Ophthalmologist magazine. Drs. Eduardo C. Alfonso, Kendall Donaldson, Hilda Capó, Janet Davis, Harry Flynn, Anat Galor, Steven Gedde, Ranya Habash, Carol Karp, Jaclyn Kovach, Byron Lam, Felipe Medeiros, Richard Parrish, Philip Rosenfeld, and Sonia Yoo were named to the 2024 Power List. Bascom Palmer Eye Institute is the Department of Ophthalmology for the University of Miami Miller School of Medicine and UHealth – University of Miami Health System.

Key Points: 
  • Bascom Palmer Eye Institute is the Department of Ophthalmology for the University of Miami Miller School of Medicine and UHealth – University of Miami Health System.
  • From cutting-edge treatments to groundbreaking research, these doctors are pushing boundaries and setting new standards in ophthalmology."
  • Alfonso, the holder of the Kathleen and Stanley J. Glaser Chair in Ophthalmology, was also named to the Ophthalmologist Power Lists 2014, 2016, 2018, 2022, and 2023.
  • Holder of the John T. Flynn Chair in Ophthalmology, Hilda Capó, M.D., specializes in pediatric ophthalmology and adult strabismus.

Lucid Diagnostics Announces Peer-Reviewed Publication of Positive Data from National Cancer Institute-Sponsored, Prospective, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing

Retrieved on: 
木曜日, 5月 2, 2024
Johns Hopkins University, University, Mayo Clinic, Cancer, SOS, American College, Case Western Reserve University, AUC, ACG, Esophageal cancer, Prevalence, Methylation, Risk, Barrett's esophagus, Cleveland Clinic, American Journal, Lucid, Adenocarcinoma, National Cancer Institute, NPV, NGS, University of North Carolina, Gold, Detection, EGD, Patient, Research report, NCI, PPV, Medicare, Manuscript, GERD, Guideline, Gastroesophageal reflux disease, Medical imaging

NEW YORK, May 2, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the peer-reviewed publication of positive data from a National Cancer Institute (NCI)-sponsored, prospective, multicenter clinical validation study assessing the performance of Lucid's EsoGuard® Esophageal DNA Test on samples collected with its EsoCheck® Esophageal Cell Collection Device. This case-control study, led by Case Western Reserve University's Amitabh Chak, M.D., was funded through the NCI's Barrett's Esophagus Translational Research Network (BETRNet), and included renowned investigators from leading academic medical centers, including Case Western Reserve University, Mayo Clinic, Johns Hopkins University, Washington University in St. Louis, University of North Carolina, and Cleveland Clinic. EsoGuard demonstrated unprecedented early precancer detection compared to the gold standard of upper endoscopy (EGD). The manuscript, entitled Multicenter, Prospective Trial of Non-Endoscopic Biomarker-Driven Detection of Barrett's Esophagus And Esophageal Adenocarcinoma, was published in the American Journal of Gastroenterology, the leading clinical journal covering gastroenterology published on behalf of the American College of Gastroenterology (ACG).

Key Points: 
  • EsoGuard demonstrated unprecedented early precancer detection compared to the gold standard of upper endoscopy (EGD).
  • Dr. Aklog concluded, "The publication of the BETRNet study is the culmination of a period of rapid expansion of EsoGuard's clinical evidence base.
  • It represents the second peer-reviewed, and third overall, clinical validation study demonstrating consistently excellent EsoGuard performance.
  • Soon to be released data from a fourth such clinical validation study tells the same story.

The Inner Circle acknowledges Mary J. Aloia-Dombrowski as a Pinnacle Professional Lifetime Member

Retrieved on: 
月曜日, 4月 29, 2024
Education, Oncology, Critical care, Palliative care, JFK Medical Center, Terminal, Travel, Hospice, State university system, Mentorship, American Journal, Death, American Cancer Society, Parent, National Association, Clinical Social Work Journal, Friends, Master, Golf, Patient, MRMC, Pinnacle, Multimedia, Philosophy, Good, Stockton University, Inner circle, Journal, Muhlenberg Regional Medical Center, Nursing

PLAINFIELD, N.J., April 29, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Mary J. Aloia-Dombrowski is acknowledged as a Pinnacle Professional Lifetime Member for her contributions to Hospice Social Work.

Key Points: 
  • PLAINFIELD, N.J., April 29, 2024 /PRNewswire/ -- Prominently featured in The Inner Circle, Mary J. Aloia-Dombrowski is acknowledged as a Pinnacle Professional Lifetime Member for her contributions to Hospice Social Work.
  • Ms. Aloia-Dombrowski is a highly respected hospice social worker currently working at Hackensack Meridian Health Hospice.
  • She enjoys reading the Journal of Social Work, Clinical Social Work Journal, and American Journal of Hospice and Palliative Medicine.
  • The most important days of your life are the day you were born and the day you figure out why."

The American Journal of Managed Care® announces call for manuscript submissions for the 14th Annual Health Information Technology Special Issue

Retrieved on: 
火曜日, 4月 23, 2024
Doctor of Philosophy, University, Health, AJMC, American Journal, Diabetes, Research, Information technology, Science, Hypertension, Conditional sentence, Manuscript, Medical device

CRANBURY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- The American Journal of Managed Care (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, today announced that it is seeking manuscript submissions for its 14th Annual Health Information Technology (IT) Special Issue, with a deadline of July 31, 2024.

Key Points: 
  • CRANBURY, N.J., April 23, 2024 (GLOBE NEWSWIRE) -- The American Journal of Managed Care (AJMC®), the leading multimedia peer-reviewed journal dedicated to issues in managed care, today announced that it is seeking manuscript submissions for its 14th Annual Health Information Technology (IT) Special Issue, with a deadline of July 31, 2024.
  • “Having been acknowledged as an expert in health care management and information technology, Lyles brings invaluable insight.
  • We’re certain that with her guidance, this special issue will become an invaluable resource for both health care professionals and researchers."
  • “The Health IT Special Issue published by AJMC is so important, especially in light of the ever-increasing pace of digital innovation,” Lyles said.

XORTX Announces Publication of Key Research in ADPKD

Retrieved on: 
月曜日, 4月 22, 2024
Kidney disease, University, Xanthine oxidase, Mouse, Kidney, Uric acid, XO, Prognosis, American Journal, Cyst, Research, Oxipurinol, SUA, Disease, Patient, Serum, Polycystic kidney disease, Therapy, PKD, Pharmaceutical industry

This study shows, for the first time, that chronically increased SUA can significantly increase cyst index and increase kidney size in ADPKD.

Key Points: 
  • This study shows, for the first time, that chronically increased SUA can significantly increase cyst index and increase kidney size in ADPKD.
  • Dr. Allen Davidoff, CEO of XORTX, stated, “We are pleased to have supported this pioneering research in polycystic kidney disease by Dr. Charles Edelstein of the University of Colorado.
  • In human ADPKD, kidney size and declining kidney filtering capacity are correlated and are key indicators of disease progression and prognosis.
  • These mechanistic studies are important for the planning of future clinical studies of xanthine oxidase inhibition in patients with ADPKD.”

Flexible morals: A key reason American voters support divisive misinformation

Retrieved on: 
火曜日, 4月 16, 2024
Alexandria Ocasio-Cortez, University, Language, COVID, Bias, American Journal, Death, Entrepreneurship, Doctor of Philosophy, Research, Vaccine, Black Lives Matter, Disease, Republican, Diagnosis, American Sociological Review, Democrat, Partisan, Politics, COVID-19

A common assumption about the problem is that partisan voters are apt to believe what they should question (and vice versa).

Key Points: 
  • A common assumption about the problem is that partisan voters are apt to believe what they should question (and vice versa).
  • And research backs up the idea that voters are “factually flexible,” either due to laziness or bias .
  • What if a key part of the story is that partisan voters are also “morally flexible” — that they hold opposition politicians to strict standards of factuality but allow their favorite politicians to share misinformation — even socially divisive misinformation.
  • For morally flexible voters, such statements are permissible because they articulate a “deeper truth” that captures their grievances.

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2

Retrieved on: 
水曜日, 4月 10, 2024
FDA, American Academy, International, MIGS, American Journal, IOP, Patient, Intraocular pressure, Medicine, Lop, OMNI, Mercury (element), Vision science

OMNI facilitates a unique implant-free, ab interno procedure that comprehensively addresses the three primary areas of resistance in the conventional outflow pathway.

Key Points: 
  • OMNI facilitates a unique implant-free, ab interno procedure that comprehensively addresses the three primary areas of resistance in the conventional outflow pathway.
  • OMNI technology has been cleared by the FDA for canaloplasty followed by trabeculotomy to reduce intraocular pressure in adult patients with primary open-angle glaucoma.
  • The primary treatment goal for the high baseline IOP group (> 18mmHg) was IOP reduction, with a secondary goal to reduce medication burden.
  • The primary treatment goal for the low baseline IOP group (

Raydiant Oximetry Secures FDA Approval for Lumerah Investigational Device Exemption (IDE) Study

Retrieved on: 
水曜日, 4月 10, 2024
FDA, Nerve, Bangladesh Technical Education Board, Investment, Eastern Virginia Medical School, EFS, Pregnancy, NIH, DSM-IV codes, IDE, American Journal, NICHD, Trial of the century, Infant, Dean (education), Female, Obstetrics, Gynaecology, EVMS, CTG, Fetal distress, Pulse oximetry, Mother, Organization, SAN, Woman

“Each year 36,000 babies in the United States suffer neurological damage, which could be prevented through better monitoring tools, such as Lumerah,” says Raydiant Oximetry founder and CEO, Dr. Neil P. Ray.

Key Points: 
  • “Each year 36,000 babies in the United States suffer neurological damage, which could be prevented through better monitoring tools, such as Lumerah,” says Raydiant Oximetry founder and CEO, Dr. Neil P. Ray.
  • Lumerah has received FDA Breakthrough Device Designation for expedited market approval.
  • Completion of the EFS study will pave the path towards FDA IDE approval for a subsequent pivotal study.
  • Raydiant Oximetry is supported by leading organizations that include the March of Dimes and the National Institutes of Health (NIH).

New Research from VillageMD Finds Regular Primary Care Visits Decrease Hospitalizations

Retrieved on: 
水曜日, 4月 17, 2024
Professional Services, Health, Data Analytics, Practice Management, Managed Care, General Health, Well, Patient, COVID, American Journal, Research, COPD, Conditional sentence, Quality of life, Heart, Chronic obstructive pulmonary disease, Nursing

A new study published in The American Journal of Managed Care demonstrates the value of high-cadence primary care visits in reducing hospitalizations among high-risk patients.

Key Points: 
  • A new study published in The American Journal of Managed Care demonstrates the value of high-cadence primary care visits in reducing hospitalizations among high-risk patients.
  • The research was conducted by VillageMD Research Institute and is titled, “Primary Care Visit Cadence and Hospital Admissions in High-Risk Patients.” Researchers found that quarterly primary care visits through Village Medical’s Stay Well Care Plan provided an opportunity to lower hospitalizations.
  • “As a primary care physician, I am heartened but not surprised by the results of this study,” said Clive Fields, M.D., co-founder and chief medical officer, VillageMD.
  • “High-quality primary care can keep patients healthier and out of the hospital, so continuity and regularity of care demonstrates the need for these quality metrics.

Outset Medical Partners with American Nephrology Nurses Association to Support Nephrology Nursing and Patient Care

Retrieved on: 
月曜日, 4月 15, 2024
Medical Devices, Other Health, Health, Health Technology, Nursing, Kidney disease, Nephrology, Policy, Kidney failure, RNS, American Journal, ANNA, Partnership, Chronic kidney disease, CKD, Patient, Dialysis, Medicine, Kidney, Chair

This collaboration underscores Outset’s dedication to supporting the nephrology nursing community and improving patient care in the realm of kidney disease.

Key Points: 
  • This collaboration underscores Outset’s dedication to supporting the nephrology nursing community and improving patient care in the realm of kidney disease.
  • Leslie Trigg, Chair and CEO of Outset, shared her thoughts on the partnership: “We enthusiastically support ANNA’s goal of empowering and educating nephrology nurses who are essential to delivering high-quality care to patients with kidney disease.
  • This partnership demonstrates our dedication to enhancing patient outcomes and supporting the vital role of the nephrology nurses who care for them.”
    ANNA emphasized the importance of collaboration with industry leaders to advance the nephrology nursing field.
  • “Outset Medical’s support, together with our other corporate partners, is important to our mission,” said Michele Kimball, ANNA Executive Director.